Quantumzyme Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTZM research report →
About the company
Quantumzyme Corp. is a biotransformation firm specializing in the creation of engineered enzymes, primarily utilized for the production of active pharmaceutical ingredients (APIs). Established in 2015, the company was formerly known as Reliant Services, Inc.
- CEO
- Naveen Krishnarao Kulkarni
- IPO
- 2024
- Employees
- 1
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $31.17M
- P/E
- -6.46
- P/S
- 0.00
- P/B
- -63.76
- EV/EBITDA
- -261.59
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 997.31%
- ROIC
- 62.54%
- Revenue
- $0 · 0.00%
- Net Income
- $-199,269 · 0.00%
- EPS
- $-0.01 · 0.00%
- Op Income
- $-180,537
- FCF YoY
- 0.00%
- 52W High
- $5.04
- 52W Low
- $0.00
- 50D MA
- $2.67
- 200D MA
- $1.04
- Beta
- 7.51
- Avg Volume
- 79.68K
Get TickerSpark's AI analysis on QTZM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our QTZM coverage
Recent articles, reports, and earnings notes.
No research on QTZM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QTZM report →Similar companies
Peers in the same neighborhood.